Burdock Group ConsultantsMar 1, 201410 minDraft Guidelines from FDA for Medical Foods: More Attempts to Limit Development of Functional Foods
Burdock Group ConsultantsDec 1, 201310 minSerious Adverse Events: Are SAEs as underreported as GAO suggests? (Part II)
Burdock Group ConsultantsNov 30, 20134 minFDA Guidance for Animal Food Additive Petitions: Expanding FDA’s Reach?
Burdock Group ConsultantsSep 1, 20138 minSerious Adverse Events: Are SAEs as underreported as GAO suggests? (Part I)
Burdock Group ConsultantsJun 1, 20137 minWhen Bad Study Design Comes Back to Bite You (Part 2): Critical Importance of the Selection of Dose
Burdock Group ConsultantsMay 31, 20135 minEvaluating the Safety and Regulations of Probiotics Added to Food
Burdock Group ConsultantsFeb 28, 20136 minDiacetyl: Inhalation of a GRAS Substance Not GRAS When It Came to Lung Disease
Burdock Group ConsultantsDec 1, 20127 minGrandfathered Dietary Ingredients, DSHEA, and the New Draft Guidance
Burdock Group ConsultantsDec 1, 20125 minDeveloping Hidden Intellectual Property Assets is an Effective Way to Build a Nutritional Portfolio
Burdock Group ConsultantsSep 1, 20125 minThe Heated Debate over FTC Claims Substantiation and the Definition of “Competent and Reliable” Scie
Burdock Group ConsultantsSep 1, 20124 minProposition 37: A Deceptive Measure That Could Be Applied to Foods Produced by Conventional Methods
Burdock Group ConsultantsSep 1, 20125 minClaims: The US vs. the European Perspective (Part 4). Will the FDA permit the same claim?
